vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and PROSPERITY BANCSHARES INC (PB). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $367.6M, roughly 1.3× PROSPERITY BANCSHARES INC). PROSPERITY BANCSHARES INC runs the higher net margin — 31.6% vs 6.8%, a 24.8% gap on every dollar of revenue. Over the past eight quarters, PROSPERITY BANCSHARES INC's revenue compounded faster (19.2% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
MD vs PB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $367.6M |
| Net Profit | $33.7M | $116.3M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | — |
| Net Margin | 6.8% | 31.6% |
| Revenue YoY | -1.7% | — |
| Net Profit YoY | 10.5% | -10.7% |
| EPS (diluted) | $0.40 | $1.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $367.6M | ||
| Q4 25 | $493.8M | $275.0M | ||
| Q3 25 | $492.9M | $273.4M | ||
| Q2 25 | $468.8M | $267.7M | ||
| Q1 25 | $458.4M | $265.4M | ||
| Q4 24 | $502.4M | $267.8M | ||
| Q3 24 | $511.2M | $261.7M | ||
| Q2 24 | $504.3M | $258.8M |
| Q1 26 | — | $116.3M | ||
| Q4 25 | $33.7M | $139.9M | ||
| Q3 25 | $71.7M | $137.6M | ||
| Q2 25 | $39.3M | $135.2M | ||
| Q1 25 | $20.7M | $130.2M | ||
| Q4 24 | $30.5M | $130.1M | ||
| Q3 24 | $19.4M | $127.3M | ||
| Q2 24 | $-153.0M | $111.6M |
| Q1 26 | — | — | ||
| Q4 25 | 9.9% | 65.1% | ||
| Q3 25 | 13.8% | 64.4% | ||
| Q2 25 | 12.8% | 64.3% | ||
| Q1 25 | 7.0% | 62.7% | ||
| Q4 24 | 7.8% | 62.0% | ||
| Q3 24 | 6.6% | 62.1% | ||
| Q2 24 | -31.3% | 55.2% |
| Q1 26 | — | 31.6% | ||
| Q4 25 | 6.8% | 50.9% | ||
| Q3 25 | 14.5% | 50.3% | ||
| Q2 25 | 8.4% | 50.5% | ||
| Q1 25 | 4.5% | 49.1% | ||
| Q4 24 | 6.1% | 48.6% | ||
| Q3 24 | 3.8% | 48.6% | ||
| Q2 24 | -30.3% | 43.1% |
| Q1 26 | — | $1.16 | ||
| Q4 25 | $0.40 | $1.48 | ||
| Q3 25 | $0.84 | $1.45 | ||
| Q2 25 | $0.46 | $1.42 | ||
| Q1 25 | $0.24 | $1.37 | ||
| Q4 24 | $0.37 | $1.36 | ||
| Q3 24 | $0.23 | $1.34 | ||
| Q2 24 | $-1.84 | $1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | — |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $8.2B |
| Total Assets | $2.2B | $43.6B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | — | ||
| Q2 25 | $224.7M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $8.2B | ||
| Q4 25 | $865.9M | $7.6B | ||
| Q3 25 | $890.7M | $7.7B | ||
| Q2 25 | $833.8M | $7.6B | ||
| Q1 25 | $789.2M | $7.5B | ||
| Q4 24 | $764.9M | $7.4B | ||
| Q3 24 | $732.5M | $7.4B | ||
| Q2 24 | $706.5M | $7.3B |
| Q1 26 | — | $43.6B | ||
| Q4 25 | $2.2B | $38.5B | ||
| Q3 25 | $2.2B | $38.3B | ||
| Q2 25 | $2.1B | $38.4B | ||
| Q1 25 | $2.0B | $38.8B | ||
| Q4 24 | $2.2B | $39.6B | ||
| Q3 24 | $2.1B | $40.1B | ||
| Q2 24 | $2.0B | $39.8B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $78.3M | ||
| Q3 25 | $137.3M | $194.8M | ||
| Q2 25 | $137.2M | $98.2M | ||
| Q1 25 | $-117.5M | $178.2M | ||
| Q4 24 | $133.0M | $-205.8M | ||
| Q3 24 | $91.8M | $274.6M | ||
| Q2 24 | $107.0M | $216.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $68.5M | ||
| Q3 25 | — | $185.7M | ||
| Q2 25 | — | $91.8M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $-210.7M | ||
| Q3 24 | — | $270.2M | ||
| Q2 24 | — | $211.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 24.9% | ||
| Q3 25 | — | 67.9% | ||
| Q2 25 | — | 34.3% | ||
| Q1 25 | — | 64.5% | ||
| Q4 24 | — | -78.7% | ||
| Q3 24 | — | 103.3% | ||
| Q2 24 | — | 81.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.6% | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 0.56× | ||
| Q3 25 | 1.91× | 1.42× | ||
| Q2 25 | 3.49× | 0.73× | ||
| Q1 25 | -5.66× | 1.37× | ||
| Q4 24 | 4.36× | -1.58× | ||
| Q3 24 | 4.72× | 2.16× | ||
| Q2 24 | — | 1.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
PB
| Net Interest Income | $321.1M | 87% |
| Noninterest Income | $46.5M | 13% |
